Satellos Bioscience Inc (MSCL.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MSCL.VN | NRX.VN | QNTM.CN | ||
| Company | Satellos Bioscience Inc | Nurexone Biologic Inc | Quantum Biopharma Ltd Cls B Subordinate Voting S | ||
| Price Information | |||||
| Exchange | TSX Venture | TSX Venture | CNSX | ||
| Open | 0.580 | 0.700 | 13.7900 | ||
| High | 0.580 | 0.700 | 14.1200 | ||
| Low | 0.560 | 0.700 | 13.0000 | ||
| Latest | 0.560 | 0.700 | 14.1200 | ||
| Change | +0.010 | unch | +0.3300 | ||
| % Change | +1.82% | unch | +2.39% | ||
| Volume | 53,750 | 18,427 | 2,800 | ||
| 20-Day Average Volume | 105,265 | 33,935 | 8,700 | ||
| Previous Close | 0.550 | 0.700 | 13.7900 | ||
| Industry | TSX Biotechnology | TSX Biotechnology | N/A | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.515 | 0.705 | 12.0880 | ||
| 20-Day Raw Stochastic | 67.74% | 20.00% | 40.13% | ||
| 20-Day Relative Strength | 60.11 | 40.88 | 48.23 | ||
| Weighted Alpha | +4.90 | -5.45 | -61.22 | ||
| Today's Opinion | 88% Buy | 56% Sell | 56% Sell | ||
| Previous Opinion | 88% Buy | 56% Sell | 56% Sell | ||
| Last Month's Opinion | 24% Buy | 24% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.70% since 02/07/24 | unch since 11/28/25 | +0.50% since 11/28/25 | ||
| Low | 0.500 on 02/12/24 | 0.685 on 12/01/25 | 11.5500 on 12/02/25 | ||
| High | 0.580 on 02/14/24 | 0.710 on 12/01/25 | 14.8500 on 12/03/25 | ||
| 1-Month | |||||
| %Chg | +21.74% since 01/12/24 | -1.41% since 11/05/25 | +14.24% since 11/05/25 | ||
| Low | 0.450 on 01/15/24 | 0.685 on 12/01/25 | 8.1000 on 11/21/25 | ||
| High | 0.610 on 01/18/24 | 0.760 on 11/24/25 | 23.1000 on 11/27/25 | ||
| 3-Month | |||||
| %Chg | +60.00% since 11/14/23 | -13.58% since 09/05/25 | -27.96% since 09/05/25 | ||
| Low | 0.350 on 11/16/23 | 0.685 on 12/01/25 | 8.1000 on 11/21/25 | ||
| High | 0.610 on 01/18/24 | 1.140 on 09/16/25 | 28.5900 on 09/19/25 | ||
| 6-Month | |||||
| %Chg | +33.33% since 08/14/23 | -1.41% since 06/05/25 | -24.09% since 06/05/25 | ||
| Low | 0.290 on 11/14/23 | 0.640 on 06/13/25 | 8.1000 on 11/21/25 | ||
| High | 0.610 on 01/18/24 | 1.140 on 09/16/25 | 52.0000 on 06/20/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 63,163 | 63,477 | 53,896 | ||
| Shares Outstanding, K | 112,792 | 90,681 | 3,817 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -11,322,437 | -5,043,000 | -14,202,724 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -3,574,000 | -1,465,000 | -5,319,029 | ||
| 60-Month Beta | N/A | 0.58 | 1.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 | -0.02 on 11/26/25 | -1.25 on 11/06/25 | ||
| Latest Earnings Date | 04/04/24 | 11/26/25 | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | N/A | N/A | ||